Technology offers: Life Science

BioTech/Pharma
- Biotechnological active substance factory*
The technology consists of an innovative platform technology fort he production of active ingredients e.g. for drugs and technical enzymes, with which intact bacteria cells are used. - Cyclic peptides: innovative peptide agents*
The technology encompasses an innovative basic technology for the pharmaceutical sector, for example.
Chemistry
- Biopolymers - extra-cellular high-yield production*
The innovation relates to a genetically engineered strain of the marine bacterium Alcanivorax borkumensis which not only hyper-produces biopolymers, but extracellular deposits them in the growth medium. - Direct oxidation of olefins* - a new method
A new continuous process fort the production of epoxides via direct oxidation of olefins with ozone and nitrogen dioxide in a flow reactor. The reaction is a homogeneous gas phase process. - Impact Modifier - Polymer additive on basis of nano technology*
The patent covers an innovative process to obtain a nano-structure of polyurethane in a reactive diluent. This improves the physical properties of plastic materials, such as transparency, impact strength, pull-out and shear strength. - Pulp from biomass: MEA pulping process*
The invention describes a new, effective industrial process fort he production of cellulose from annual plants such as straw, rice straw, bagasse and annual plant litter.
MedTech
- MicroJet-Technology*
The non-contact dispenser permits highly precise droplet dispensing and is, at the same time, suitable for a wide range of media. It permits the generation of droplets in a volume range between 100 picolitres and one nanolitre.
*The patents are owned by ZYRUS Beteiligungsgesellschaft mbH & Co. Patente I KG
*The patents are owned by ZYLUM Beteiligungsgesellschaft mbH & Co. Patente II KG
*The patents are the property of Dritte Patentportfolio Beteiligungsgesellschaft mbH & Co. KG
